AI MARKET SCANNING

MeiraGTx Holdings plc

📅 Next Catalyst: Nov 12, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP +2.47%
MAX GAP RECORD +20.59%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $MGTX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 12, 2026 Earnings Release 2026-11-12 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE)
+9.49%
May 13, 2026 Earnings Release 2026-05-13 (BEFORE OPEN)
-0.31%
Mar 26, 2026 Earnings Release 2026-03-26 (BEFORE OPEN)
+0.26%
Nov 13, 2025 Earnings Release 2025-11-13 (BEFORE OPEN)
-1.04%
Aug 14, 2025 Earnings Release 2025-08-14 (BEFORE OPEN)
+1.20%
May 13, 2025 Earnings Release 2025-05-13 (BEFORE OPEN)
-0.18%
Mar 13, 2025 Earnings Release 2025-03-13 (BEFORE OPEN)
+20.59%

VOLATILITY & GAP BIAS

AVG GAP MOVE 3.2%
Bullish Gaps (7)
Bearish Gaps (3)
Neutral / Flat (5)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $MGTX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

MeiraGTx Holdings Plc is a clinical-stage genetic medicines company with a broad pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It targets local delivery of small doses of genetic medicines to treat both inherited and more common conditions with severe unmet needs. The company…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗